STAT+: Sophisticated phishing and deepfakes: How generative AI brings new threats for hospitals
The ubiquity of AI tools like ChatGPT could be a boon to hospitals eager for…
Category: STAT+
STAT+: European regulators tout their accomplishments against pharma’s anticompetitive practices
European antitrust regulators want you to know that fighting crime in the pharmaceutical industry pays….
STAT+: Pharmalittle: We’re reading about Medicaid and sickle cell, pharma CEOs, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Pricey sickle cell treatments raise daunting new challenges for Medicaid programs
Living with sickle cell disease has not been easy on Kourtney Cunningham. The genetic blood…
STAT+: Cognito raises $35 million for Alzheimer’s treatment device, touts benefits compared to drugs
Just as a new wave of approved drugs for Alzheimer’s disease reaches patients, medical device…
.jpg)
STAT+: From a small town in Wales, a scientific sleuth has shaken Dana-Farber — and elevated the issue of research integrity
PONTYPRIDD, Wales — The blog post that has shaken the leadership of Boston’s Dana-Farber Cancer…
STAT+: Merck, Johnson & Johnson CEOs agree to testify in Congress on high drug prices, avoiding Bernie Sanders’ subpoena
WASHINGTON — Merck CEO Robert Davis and Johnson and Johnson CEO Joaquin Duato have agreed…
STAT+: Vaccines save lives and generate profits. Why is investment lagging?
Covid vaccines saved nearly 20 million lives worldwide, by one estimate, and generated billions of…
STAT+: Pharmalittle: We’re reading about Sanders jabbing Merck’s CEO, fixing drug shortages, and more
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Democrats urge government to rein in Medicare Advantage overpayments and denials
The Biden administration is about to set the ground rules for next year’s Medicare Advantage…
STAT+: FTC sues to block a proposed hospital deal in North Carolina
The federal government is suing to block a proposed hospital deal in North Carolina, alleging…
STAT+: Generic group sues Illinois over a price-gouging law with ‘draconian regulations’
The trade group for generic drug companies in the U.S. has filed a lawsuit alleging…
STAT+: Humana projects a tough road for Medicare Advantage, sinking its stock
Humana’s Medicare Advantage business is faring even worse than the company let on last week,…
STAT+: Key Senate panel considers Medicare bonuses for hospitals that prevent drug shortages
WASHINGTON — A key Senate committee is proposing that Medicare pay bonuses to hospitals that…
STAT+: Pharmalittle: We’re reading about fake Ozempic, the FTC policing pharma, and more
Rise and shine, everyone, another busy day is on the way. Sadly, gray skies are…
STAT+: As biotech VCs struggle to raise money, some debate whether the worst is over
Over the last year or two, something curious has started occurring in the conference rooms…
STAT+: What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s surprising rise
Hello! Some takes and thoughts on Gilead’s Trodelvy troubles, Elevation Oncology’s surprising rise, and Kura…
STAT+: A PBM in Africa flips the industry’s script in a bid to make people healthier
WASHINGTON — For an app that helps pharmacies in Africa manage their medicines, the term…
STAT+: When it comes to policing pharma, the FTC says it’s on ‘an incredible winning streak’
Over the past two years, the U.S. Federal Trade Commission has attempted to crack down…
.jpg)
STAT+: Osteoarthritis might be linked to protein known for its role in Alzheimer’s, study says
A kind of protein implicated in Alzheimer’s disease might also contribute to the breakdown of…
STAT+: Pharmalittle: We’re reading about Lilly’s gene therapy for hearing, Shkreli’s life-long ban, and more
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: FDA OKs — but doesn’t require — a non-cancer-causing chemical for sterilizing devices
The chemical used to sterilize half of all medical devices in the United States is…
STAT+: Pharmalittle: We’re reading about FDA warnings on CAR-T drugs, a Sanofi deal, and more
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Pharma’s attack on Medicare drug price negotiation might benefit Biden
WASHINGTON — Pharmaceutical companies are doing anything they can to stop President Biden’s Medicare program…
STAT+: Sanofi scoops up U.S. biotech Inhibrx for up to $2.2 billion as it seeks to bolster pipeline
LONDON — In a bid to expand its pipeline of inflammation-targeting drugs, Sanofi said Tuesday…
STAT+: Pharmalittle: We’re reading about Lilly plant problems, FDA reorganization plans, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Gilead’s Trodelvy fails in lung cancer and raises new questions on antibody drug conjugate drugs
Gilead Sciences said Monday that Trodelvy, its “smart-bomb” medicine that combines an antibody with chemotherapy,…
Opinion: STAT+: Some countries are moving to digital prescription drug information for patients. The U.S. shouldn’t follow suit
Getting a new prescription can be overwhelming: medication schedules, foods to eat or avoid, interactions…
STAT+: In ‘march-in’ rights, some see a tool to lower drug prices. Others see a threat to intellectual property
In the fall of 2020, Robert Sachs was prescribed a medication to treat prostate cancer…
STAT+: Physician buy-in will make or break VC firm General Catalyst’s bold hospital deal
It makes sense in theory for hospitals and startups to strike deals. Not only would…
STAT+: FDA sets aggressive deadline for inspection overhaul
WASHINGTON — Food and Drug Administration officials hope to finish this year a massive overhaul…
STAT+: Dana-Farber cancer researchers moving to retract one paper, correct others in broad investigation of manipulated data
Scientists at Dana-Farber Cancer Institute, one of the nation’s leading cancer research and treatment centers,…
STAT+: FDA scolds Novartis over a misleading TV ad for a breast cancer treatment
The U.S. Food and Drug Administration scolded Novartis for making false and misleading statements about…
STAT+: Pharmalittle: We’re reading about Sanders targeting pharma CEOs, insider trading, and more
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Hospitals offer their custom-built tech for sale in search of new revenue streams
Hospitals aren’t usually in the business of selling technology tools. But that’s changing thanks to…
Opinion: STAT+: The necessary roughness of 2023 has set up a very promising 2024 for biotech jobs
What a week — this year’s might have been the busiest JPM I’ve ever had….
STAT+: The FDA’s diagnostics chief, who led through Covid, has retired
Timothy Stenzel, the federal regulator who led the Food and Drug Administration’s diagnostics division during…
STAT+: Klobuchar urges drugmakers to remove patents FTC calls improper and inaccurate
Amid a push to crack down on patent abuse by the pharmaceutical industry, a key…
STAT+: Microsoft to embed AI tool for clinical documentation in Epic’s health records software
Microsoft on Thursday said it will launch its artificial intelligence tool for automating clinical documentation…
STAT+: Humana slashes profit predictions amid soaring Medicare Advantage costs
Humana’s Medicare Advantage enrollees got care in the hospital and physician clinics way more often…
STAT+: Bernie Sanders proposes subpoenas of CEOs of J&J, Merck on drug prices
WASHINGTON — Senate health committee chair Bernie Sanders has taken a step toward subpoenaing the…
STAT+: CRISPR-edited pig liver from eGenesis passes first test in brain-dead human, researchers say
For three days in December, an ICU room at the Hospital of the University of…
STAT+: Apple removes pulse oximeter feature in Watches to comply with ban
Apple will remove the blood oxygen measurement feature from its Apple Watches, the company announced…
STAT+: Pharmalittle: We’re reading about drug price hikes, Bayer strategic moves, and more
Rise and shine, everyone, another busy day is on the way. Sadly, gray skies are…
STAT+: How digital therapeutics companies are improvising when insurance coverage isn’t guaranteed
For years, the playbook for many companies that wanted to market digital therapeutics was stupid…
STAT+: Congress’ negotiations over doc pay, health centers fell apart ahead of spending extension
WASHINGTON — Negotiations to add extra health care policies to Congress’ stopgap funding bill fell…
STAT+: Testosterone didn’t lower fracture risk in a surprising new study. Researchers have theories about why
Testosterone is essential for bone health in men. It helps maintain bone density and improve…
STAT+: Biden changes will force health insurers to speed up and get more specific if they want to deny care
The Biden administration moved Wednesday to force insurance companies to give specific reasons for denying…
STAT+: Copay coupons for some drugs must count toward deductibles, after Biden court move
WASHINGTON — Insurers will have to count drug copay coupons toward deductibles and patient spending…
General Catalyst to buy Ohio-based health system Summa Health
Venture capital firm General Catalyst has agreed to acquire Ohio-based nonprofit health system Summa Health…